QTL |
GWAS Catalog Study |
Disease Trait |
Study Size |
Risk Allele |
Risk Allele Frequency |
P Value |
P Value MLOG |
Peak Marker |
Reported Odds Ratio or Beta-coefficient |
Ontology Accession |
PubMed |
GWAS540394_H |
GCST90240434 |
Beta-endorphin levels (POMC.2558.51.3) |
3,301 European ancestry individuals |
C |
0.916 |
5E-44 |
43.302 |
rs5128 |
0.6 |
beta-endorphin measurement (EFO:0008034)
|
PMID:29875488 |
GWAS767956_H |
GCST90270118 |
Multi-trait sex score |
141,980 European ancestry males |
? |
NR |
6E-33 |
32.222 |
rs5128 |
N/A |
sexual dimorphism measurement (EFO:0021796)
|
PMID:37277458 |
GWAS813608_H |
GCST90060511 |
Triacylglycerol_52:2_[M+NH4]1+ levels |
13,814 British ancestry individuals |
G |
NR |
4E-10 |
9.398 |
rs5128 |
0.161754 |
triglyceride measurement (EFO:0004530)
|
PMID:34503513 |
GWAS814759_H |
GCST90060191 |
Diacylglycerol_36:2_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-11 |
10.699 |
rs5128 |
0.124889 |
diacylglycerol 36:2 measurement (EFO:0010355)
|
PMID:34503513 |
GWAS816512_H |
GCST90060509 |
Triacylglycerol_52:3_[M+NH4]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-10 |
9.699 |
rs5128 |
0.164684 |
triglyceride measurement (EFO:0004530)
|
PMID:34503513 |
GWAS817611_H |
GCST90060178 |
Diacylglycerol_34:2_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
G |
NR |
1E-11 |
11 |
rs5128 |
0.125272 |
diacylglycerol 34:2 measurement (EFO:0010353)
|
PMID:34503513 |
GWAS819814_H |
GCST90060240 |
Diacylglycerol_44:7_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
G |
NR |
5E-14 |
13.302 |
rs5128 |
0.154266 |
diacylglycerol 44:7 measurement (EFO:0020069)
|
PMID:34503513 |
None Available |
GCST90060179 |
Diacylglycerol_34:1_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-11 |
10.699 |
rs5128 |
0.127303 |
diacylglycerol 34:1 measurement (EFO:0010352)
|
PMID:34503513 |
GWAS821438_H |
GCST90060133 |
Cholesterol_[M+H-H2O]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-14 |
13.699 |
rs5128 |
0.11917 |
sterol measurement (EFO:0010231)
|
PMID:34503513 |
GWAS824172_H |
GCST90060218 |
Cholesteryl ester_18:3_[M+NH4]1+ levels |
13,814 British ancestry individuals |
G |
NR |
3E-10 |
9.523 |
rs5128 |
0.114476 |
cholesteryl ester 18:3 measurement (EFO:0010346)
|
PMID:34503513 |
None Available |
GCST90060333 |
Triacylglycerol_45:4_[M+NH4]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-10 |
9.699 |
rs5128 |
0.131882 |
triglyceride measurement (EFO:0004530)
|
PMID:34503513 |
GWAS846946_H |
GCST90060362 |
Triacylglycerol_46:4_[M+NH4]1+ levels |
13,814 British ancestry individuals |
G |
NR |
3E-11 |
10.523 |
rs5128 |
0.171523 |
triglyceride measurement (EFO:0004530)
|
PMID:34503513 |
GWAS854204_H |
GCST90060277 |
Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
4E-11 |
10.398 |
rs5128 |
0.140425 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS856064_H |
GCST90060243 |
Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
7E-11 |
10.155 |
rs5128 |
0.133485 |
phosphatidylcholine measurement (EFO:0010226)
|
PMID:34503513 |
GWAS886584_H |
GCST90060241 |
Sphingomyelin_34:0_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
3E-14 |
13.523 |
rs5128 |
0.155673 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
GWAS888670_H |
GCST90060269 |
Sphingomyelin_36:0_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
5E-12 |
11.302 |
rs5128 |
0.140211 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
GWAS915816_H |
GCST90060266 |
Sphingomyelin_36:1_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
9E-13 |
12.046 |
rs5128 |
0.149093 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90060328 |
Sphingomyelin_39:1_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-11 |
10.699 |
rs5128 |
0.139934 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90060239 |
Sphingomyelin_34:1_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-14 |
13.699 |
rs5128 |
0.1627 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90060403 |
Sphingomyelin_42:2_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
3E-10 |
9.523 |
rs5128 |
0.158509 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90060364 |
Sphingomyelin_40:0_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-11 |
10.699 |
rs5128 |
0.171238 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90060358 |
Sphingomyelin_40:1_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
7E-11 |
10.155 |
rs5128 |
0.170165 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
GWAS918471_H |
GCST90060306 |
Sphingomyelin_38:1_[M+H]1+ levels |
13,814 British ancestry individuals |
G |
NR |
2E-17 |
16.699 |
rs5128 |
0.175826 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34503513 |
None Available |
GCST90454454 |
Metabolic syndrome |
24,171 Taiwanese ancestry cases, 83,059 Taiwanese ancestry controls |
C |
0.3061 |
1E-13 |
13 |
rs5128 |
0.08526 |
metabolic syndrome (EFO:0000195)
|
PMID:38201907 |